Get started
Zhong Yuan Bio-Technology Holdings LtdZhong Yuan Bio-Technology Holdings LtdZhong Yuan Bio-Technology Holdings Ltd

Zhong Yuan Bio-Technology Holdings Ltd

No trades
See on Supercharts
Overview
Financials
Ideas Discussions Technicals Seasonals

ZHYBF fundamentals

Key facts

Market capitalization—
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)—
Founded—
Employees (FY)—
CEO—
Website—
About

Zhong Yuan Bio-Technology Holdings Ltd. engages in the research and development of early detection kits for brain diseases, plant-derived nervonic acid health supplements and new drugs for neurological diseases. It also develops new drugs to treat cognitive impairment, brain atrophy and other encephalopathies caused by brain white matter damage. The company was founded on April 4, 2016 and is headquartered in Hong Kong.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

ZHYBF does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company